Skip to content

Effect of Personalized Robotic Therapy

Effect of an Automatic Personalized Robot-assisted Rehabilitation on Cortical Organization and Clinical Recovery After Stroke

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02770300
Enrollment
28
Registered
2016-05-12
Start date
2016-05-31
Completion date
2020-12-31
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

automatic, personalized, robotic therapy

Brief summary

The primary goal of this project is to test the safeness and clinical effectiveness of a novel exoskeleton for the upper limb (Arm Light Exoskeleton Rehab Station, ALEx RS) developed at Wearable Robotics srl, for the force assistance of stroke patients during robotic-rehabilitation. The secondary study aim is to design and test an automatic personalized robot-based upper limb motor rehabilitation protocol targeting the specific kinematic performance of each patient. Finally, the study also aims to define the neuro-biomechanical state of the patient and its evolution during the therapy by studying cortical signals and muscular synergies. This information will be used to improve the personalization of the robotic treatment by targeting not only the motor performance but also the cerebral and muscular activity of the patient. The study is longitudinally designed in order to test the safeness and clinical effectiveness of ALEx RS over time, and to monitor the clinical effectiveness of the automatic personalized robotic therapy from the beginning until the end of the treatment. Moreover, in order to estimate the long-term clinical effectiveness of the treatment, the assessment methods proposed in the clinical trial will be repeated one month after the end of the treatment.

Interventions

DEVICEArm Light Exoskeleton Rehab Station (ALEx RS)

ALEx RS is a complete system specifically designed to support the rehabilitation of stroke patients. In particular, this system is equipped with a robotic arm exoskeleton conceived for the force assistance, integrated in a Virtual Reality system that allows implementing rehabilitative exercises highly interactive and engaging for the patients. It is proven that the use of this type of devices in rehabilitation can provide high intensive, repetitive, task specific, and interactive treatment of the impaired arm and an objective and reliable mean for monitoring patients' progress.

DEVICEArm Light Exoskeleton Rehab Station (ALEx RS) - automatically personalized

ALEx RS is a complete system specifically designed to support the rehabilitation of stroke patients. In particular, this system is equipped with a robotic arm exoskeleton conceived for the force assistance, integrated in a Virtual Reality system that allows implementing rehabilitative exercises highly interactive and engaging for the patients. It is proven that the use of this type of devices in rehabilitation can provide high intensive, repetitive, task specific, and interactive treatment of the impaired arm and an objective and reliable mean for monitoring patients' progress. The movements to be performed by the patient are automatically decided by the exoskeleton.

Sponsors

University Hospital, Geneva
CollaboratorOTHER
Azienda Ospedaliero, Universitaria Pisana
CollaboratorOTHER
Ecole Polytechnique Fédérale de Lausanne
CollaboratorOTHER
Wearable Robotics srl.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* stroke patients * right and left hand dominant * cerebral lesion onset between 2-8 weeks * able to participate in a session of about 30-60 minutes * right-hemiplegic with at least 10° of motion in the treated joints (shoulder and elbow) * age: more than 18 years old

Exclusion criteria

* subjects with an active implantable device or wearing an active device (e.g., pacemakers, metallic objects in the brain, infusion pumps, etc.) * persistent delirium or disturbed vigilance * moderate or severe language comprehension deficits * skull breach * new stroke lesions during rehabilitation * patients incapable of discernment * subjects with reduced mobility due to previous injuries or abnormalities unrelated with the cerebral accident

Design outcomes

Primary

MeasureTime frame
Safety evaluated through the number of adverse events2 years
Efficacy evaluated through Fugl-Meyer2 years

Secondary

MeasureTime frameDescription
Efficacy of personalized therapy evaluated through Fugl-Meyer2 yearsThe secondary outcome of the study is the evaluation of the differences on the outcome for a personalized vs a standard robotic rehabilitation

Other

MeasureTime frameDescription
Neurobiomechanical state evaluated through kinematics2 yearsDefinition of the neurobiomechanical state of the patient and its evolution during the therapy
Neurobiomechanical state evaluated through brain activity measured with functional Magnetic Resonance Imaging (fMRI)2 yearsDefinition of the neurobiomechanical state of the patient and its evolution during the therapy
Neurobiomechanical state evaluated through muscle activity measured with electromyography (EMG)2 yearsDefinition of the neurobiomechanical state of the patient and its evolution during the therapy
Neurobiomechanical state evaluated through brain activity measured with electroencephalography (EEG)2 yearsDefinition of the neurobiomechanical state of the patient and its evolution during the therapy

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026